A clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. We believe cell therapies are one of the forward pillars of medicine, and our mission is to advance humanity by engineering cell therapies that are safer, more effective and more broadly accessible.
Lead Underwriter
Barclays Capital Inc, BofA Securities, Inc, SVB Leerink LLC, William Blair & Company, L.L.C.
